Publication Cover
Human Fertility
an international, multidisciplinary journal dedicated to furthering research and promoting good practice
Volume 16, 2013 - Issue 3
400
Views
14
CrossRef citations to date
0
Altmetric
IVF/ICSI

Addition of prednisolone and heparin in patients with failed IVF/ICSI cycles: a preliminary report of a clinical trial

, , , , , & show all
Pages 207-210 | Received 23 Sep 2012, Accepted 16 Jan 2013, Published online: 08 Jul 2013

References

  • Akhtar, M., Sur, S., Raine-Fenning, N., Jayaprakasan, K., Thornton, J.G., & Quenby, S. (2011). Heparin for assisted reproduction. Cochrane Database of Systematic Reviews, 11, CD009452.
  • Al-Inany, H.G., Youssef, M.A., Aboulghar, M., Broekmans, F., Sterrenburg, M., Smit, J., & Abou-Setta, A.M. (2011). Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database of Systematic Reviews, 5, CD001750.
  • Bohlmann, M.K. (2011). Effects and effectiveness of heparin in assisted reproduction. Journal of Reproductive Immunology, 90, 82–90.
  • Boomsma, C.M., Keay, S.D., & Macklon, N.S. (2007).Peri-implantation glucocorticoid administration for assisted reproductive technology cycles. Cochrane Database of Systematic Reviews, 1, CD005996.
  • Comper, W.D. (ed). (1981). Heparin (and related polysaccharides) structural and functional properties. London: Gordon and Breach Publication Group.
  • Nelson, S.M. & Greer, I.A. (2008). The potential role of heparin in assisted conception. Human Reproduction Update, 14, 623–645.
  • Pandian, Z., Keay, S.D., & Bhattacharya, S. (2004).Glucocorticoid supplementation during ovarian stimulation for IVF or ICSI (Protocol).Cochrane Database of Systematic Reviews, 1, CD004752.
  • Primi, M.P., Senn, A., Montag, M., Van der Ven, H., Mandelbaum, J., Veiga, A., et al. (2004). A European multicentre prospective randomized study to assess the use of assisted hatching with a diode laser and the benefit of an immunosuppressive/antibiotic treatment in different patient populations. Human Reproduction, 19, 2325–2333.
  • Taniguchi, F. (2005). Results of prednisolone given to improve the outcome of in vitro fertilization-embryo transfer in women with antinuclear antibodies. Journal of Reproductive Medicine, 50, 383–388.
  • Tarlatzis, B.C., Zepiridis, L., Grimbisis, G., & Bontis, J. (2003).Clinical management of low ovarian response to stimulation for IVF: a systematic review. Human Reproduction Update, 9, 61–76.
  • Ubaldi, F.L., Rienzi, S., Ferrero, R., Anniballo, R., Iacobelli, M., Cobellis, L., & Greco, E. (2002). Low dose prednisolone administration in routine ICSI patients does not improve pregnancy and implantation rates. Human Reproduction, 17, 1544–1547.
  • Urman, B., Ata, B., Yakin, K., Alatas, C., Aksoy, S., Mercan, R., & Balaban, B. (2009). Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Human Reproduction, 24, 1640–1647.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.